Pesquisa de referências

Future of diagnostics : personal genetics services due for explosive growth

Recurso electrónico / Electronic resource
Registro MARC
Tag12Valor
LDR  00000cam a22000004b 4500
001  MAP20170035831
003  MAP
005  20171107133719.0
008  171107s201710 usa|||| ||| ||eng d
040  ‎$a‎MAP‎$b‎spa‎$d‎MAP
0410 ‎$a‎eng
084  ‎$a‎931
1001 ‎$0‎MAPA20170014812‎$a‎Wylie, Craig
24500‎$a‎Future of diagnostics‎$b‎: personal genetics services due for explosive growth‎$c‎Craig Wylie
260  ‎$a‎Madrid‎$b‎Arthur D. Little‎$c‎cop. 2017
300  ‎$a‎12 p.
520  ‎$a‎Access to genetic information is becoming critical to the effectiveness of a new wave of medical treatments that are becoming available now. Personalized genetic services companies will act as a disruptive forces that are consumerizing genomic testing and driving rapid transformation of an industry that we expect to become a major force in personalized medicine. In this report, we consider how large this industry is likely to get in the next 10 years and start to evaluate how pharmaceutical companies, payers, providers and medtech companies will be impacted by the shift. We believe the emergence of ever cheaper testing technology means manufacturers can enhance clinical trials, payers can be selective in authorizing treatment payouts, and patients can have more confidence in outcomes
650 4‎$0‎MAPA20080591885‎$a‎Medicina preventiva
650 4‎$0‎MAPA20080547424‎$a‎Genética
650 4‎$0‎MAPA20080557850‎$a‎Diagnóstico
650 4‎$0‎MAPA20080586546‎$a‎Nuevas tecnologías
650 4‎$0‎MAPA20080591526‎$a‎Información privada
650 4‎$0‎MAPA20080588533‎$a‎Tratamiento médico
7102 ‎$0‎MAPA20080440602‎$a‎Arthur D. Little